Alzheimer’s campaigners and charities have urged the government to act after a new “wonder drug” was ruled too expensive for the NHS.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved lecanemab after clinical trials revealed it slowed mental decline by 27 per cent in early Alzheimer’s patients. However, the National Institute for Health and Care Excellence (NICE) said the benefits are “just too small to justify the significant cost to the NHS” – so the drug will only be available privately.
Alzheimer’s Research UK branded the decision “deeply disappointing” and has urged Wes Streeting to ensure patients are granted access to potentially life-changing treatments. In a letter seen by The Independent, Hilary Evans-Newton, chief executive of Alzheimer’s Research UK, made a direct plea to the health secretary.
“On behalf of our supporters, Alzheimer’s Research UK are calling on you to help the NHS be fit for the future of dementia. Your leadership in bringing together key stakeholders is needed to help enable fast and equitable access to a new generation of treatments,” Ms Evans said.
Diese Geschichte stammt aus der August 23, 2024-Ausgabe von The Independent.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der August 23, 2024-Ausgabe von The Independent.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Stop buying clothes now!
As fashion campaigners demand 'degrowth' for an industry responsible for 10 per cent of global pollution, Helen Coffey talks to designers and activists about how, with 100 billion garments made every year, we risk shopping till we drop
The inspiration at heart of Slot and Guardiola's rivalry
Liverpool and Man City bosses set to meet for the first time
Has Bethell's Test cricket baptism come too soon?
Jacob Bethell, 21, has been thrust into England side based on potential. Could the risk backfire, asks Cameron Ponsonby
Resurgent Arsenal thrash Hammers in giddy goal fest
Arsenal plundered another hatful of goals at West Ham as they climbed up to second in the Premier League with a frenetic 5-2 victory.
Defensive Lionesses cancel USA in tactical stalemate
Another night of learning for England and Sarina Wiegman, even if the only fireworks produced from the visit of Emma Hayes and the United States were those in the pre-match light show at Wembley.
Grandmother lost savings and her business after being wrongly charged with fraud
Krista Brown receives 'unreserved' apology after seven-year ordeal at hands of Crown Prosecution Service and HMRC
Indian women are being 'controlled' by forest drones
Researchers say wildlife cameras are used to harass them
Rebels seize control of Aleppo in blow to Assad
Thousands of opposition forces took control of Syria’s second city Aleppo and its airport in a shock assault that marked their largest advance and the biggest challenge facing Syrian president Bashar al-Assad in years.
Ukraine could use a Trump peace deal to buy some time
After Putin's brutal invasion of Ukraine, Western leaders repeated constantly that they would stand behind Kyiv \"as long as it takes\", first as Ukraine struck back, then as Russia counterattacked.
Zelensky's plan for peace a 'major concession' to Putin
UK's former ambassador to Russia praises Ukraine president
